Tuesday, November 19, 2013
7:45 AM / Registration & Sign-In
8:15AM / Welcome and Introductions
ZelalemTemesgen, M.D., John Wilson, M.D., Stacey Rizza, M.D.
8:30AM / Pre-Test
8:45AM / Epidemiology of Tuberculosis
Deb Sodt, R.N., P.H.N., M.P.H.
UAN: 0853-0000-018-L01-P
Contact Hours: .75
Objectives:
•Describe the TB epidemic in terms of susceptible groups
•Describe major factors that will affect future trends in TB
•Describe how HIV plays an important role in the epidemiology of TB
9:30AM / TB Pathogenesis
Stacey Rizza, M.D.
UAN: 0853-0000-13-019-L01-P
Contact Hours: .75
Objectives:
- Explain how M. tuberculosis is transmitted
- Describe the pathogenesis of M. tuberculosis
- Explain how drug-resistant TB disease develops
10:15AM / Break
10:30AM / Infection Control
Priya Sampathkumar, M.D.
UAN: 0853-0000-13-020-L01-P
Objectives:
- Describe the components of an effective infection control program
- Explain administrative, engineering controls, and respiratory protection (CNTC)
- Describe ways healthcare workers can protect themselves and others from being infected with M. tuberculosis (CNTC)
11:15AM / Testing for TB Infection and Disease
Joshua Jones, M.D.
UAN: 0853-0000-13-023-L01-P
Contact Hours: .75
Objectives:
- Describe targeted testing strategies (CNTC)
- Explain how to interpret interferon-gamma release assay (IGRA) results
- Describe the differences between IGRAs and the TST
12:00PM / Lunch
1:15 PM / Advances in Laboratory TB Diagnosis
Nancy Wengenack, Ph.D.
UAN: 0853-0000-13-021-L01-P
Contact Hours: .75
Objectives:
- Describe laboratory methods used for the detection, identification, genotyping, and drug susceptibility testing of M. tuberculosis
2:00PM / Treatment of Latent TB Infection
Timothy Aksamit, M.D.
UAN: 0853-0000-13-022-L01-P
Contact Hours: .75
Objectives:
- Describe the current guidelines for LTBI treatment (
- Describe monitoring recommendations for patients on LTBI treatment
- Explain management strategies for TB patients with co-morbid conditions (e.g., HIV/AIDS)
- Explain treatment and management strategies for certain populations (e.g., children) (
2:45 PM / Break
3:00PM / Treatment of TB Infection
Jennifer Whitaker, M.D.
UAN: 0853-0000-13-024-L01-P
Objectives:
- Describe the current guidelines for the treatment of TB disease
- Describe the common adverse reactions to TB treatment regimens
- Explain how to manage adverse reactions to TB treatment regimens
3:45PM / Clinical Case Discussion
Kiran Belani, M.D.
UAN: 0853-0000-13-025-L01-P
Contact Hours: 1
Objectives:
•Demonstrate transfer of knowledge of tuberculosis testing, diagnosis, and treatment to a clinical case.
4:45PM / Adjourn
Wednesday, November 20, 2013
8:00 AM / Sign-in
8:30AM / Review / Q & A
ZelalemTemesgen, M.D., John Wilson, M.D., Stacey Rizza, M.D.
8:45AM / Managing Adverse Drug Reactions
Dean Tsukayama, M.D.
UAN: 0853-0000-13-026-L01-P
Contact Hours: .75
Objectives:
- Describe the common adverse reactions to TB treatment regimens
- Explain how to manage adverse reactions to TB treatment regimens
9:30AM / Management of Drug Resistant TB
John Wilson, M.D.
UAN: 0853-0000-13-026-L01-P
Contact Hours: .75
Objectives:
-Describe factors responsible for delayed response and/or treatment failure
-Describe treatment and management strategies for multidrug-resistant TB
10:15AM / Break
10:30 AM / Management of TB in Children and Adolescents
Ritu Banerjee, M.D., Ph.D.
UAN: 0853-0000-13-028-L01-P
Contact Hours: .75
Objectives:
•Describe the epidemiology of pediatric TB in the US
•Describe the clinical presentation of TB in children
•Describe treatment regimens for pediatric LTBI and active TB
11:15AM / Lunch
12:45PM / TB/HIV Co-Infection
Zelalem Temesgen, M.D.
UAN: 0853-0000-13-029-L01-P
Contact Hours: .5
Objectives:
•Describe the epidemiology of TB/HIV co-infection
•Describe clinical presentation of TB disease in populations with HIV
•Explain treatment and management strategies for TB patients with HIV.
1:15 PM / TB and Correctional Facilities
Michael Nelson, D.O.
UAN: 0853-0000-13-030-L01-P
Contact Hours: .75
Objectives:
•Explain the differences in TB epidemiology between correctional facilities and the US general population
•Describe an outbreak contact investigation to illustrate both the problems of, and opportunities for, the prevention and control of tuberculosis in correctional facilities
2:00 PM / Break
2:15PM / Case Management
Judith B. Thomas, R.N., Shea Rabley, R.N.
UAN: 0853-0000-13-031-L01-P
Contact Hours: .75
Objectives:
- List basic epidemiology tools for TB case management
- List the three steps of laboratory examination necessary for adequate TB case management
- List four basic principles for the medical management of TB cases
- List the primary components of the TB case management model
3:00PM / Clinical Case Discussion
Ritu Banerjee, M.D., Ph.D.
UAN: 0853-0000-13-032-L01-P
Contact Hours: 1
Objectives:
•Demonstrate transfer of knowledge of tuberculosis testing, diagnosis, and treatment to a clinical case.
4:00PM / TB Resource Review
Jennifer Curran
UAN: 0853-0000-13-033-L01-P
Contact Hours: .25
Objectives:
- Identify the TB resources available for health care professionals.
4:15PM / Post-test and Evaluation
4:30 / Adjourn